T Srl Inc

Asterand plc is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. Our mission is to provide human based solutions to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.Asterand plc has a well established human tissue heritage, having been formed in 2006 through the merger of Asterand ( founded 2000 ), a human tissue biorepository and Pharmagene ( founded 1996 ) a human tissue-based drug discovery company. Our expertise has been further strengthened following the acquisition of BioSeek in February 2010. BioSeek ( founded 2000 ) brings proprietary, primary cell-based models of human disease biology that provide early insight into human pharmacological and toxicological properties of compounds through comparison of resulting data profiles with an established and growing database of profiles for known compounds.With this background and capibility in human tissue procurement, characterization and research, Asterand is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From our offices in Royston ( UK ), Detroit ( MI ) and San Francisco ( CA ) we have more than 100 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety.

Jodon Engineering, based in Ann Arbor, MI, is currently in the process of creating an impressive new platform to showcase its engineering capabilities. The company is dedicated to building innovative solutions and promises exciting developments in the near future. As the site undergoes construction, Jodon Engineering encourages visitors to stay tuned for updates on their projects and offerings. Their commitment to excellence hints at a bright future for the organization in the engineering sector. Generated from the website

The KressWorks Foundation, founded in 2010 by scientist and engineer Jim Kress, is dedicated to advancing cancer research through a unique Systematic Treatment Methodology. This innovative approach focuses on developing personalized treatment plans aimed at treating and curing cancer while preserving the humane element of each patient. With a commitment to filling gaps in traditional cancer research, the foundation advocates for a coordinated systems engineering approach that emphasizes collaboration and comprehensive answers to individual questions in the field. Through their efforts, they aim to change medicine and save lives, making significant strides in the pursuit of effective cancer treatments. Generated from the website